AUS
NZ
UK
CA
USA
IND
Pfizer Inc. and BioNTech SE increased their COVID-19 vaccine manufacturing target for the current year to 2 billion doses in the wake of higher global demands. Stocks of BioNTech (BNTX:US or NASDAQ: BNTX) and Pfizer Inc. (PFE:US or NYSE: PFE) soared nearly 4 per cent and 1 per cent, respectively, on Monday morning (10:43 AM ET), January 11.
The drug producers have already assured the delivery of over 1.3 million doses, BioNTech said in an official statement. The latest increase is almost a 54 per cent rise from the previ2021 target of 1.3 billion shots. This latest boost includes a label change that will permit doctors to extract six shots from each vaccine container, BioNTech stated.
Vaccine makers have become more conscious after a rapid-spreading variant of the coronavirus that was first identified in the UK. Due to the new COVID-19 mutant, the European Union last week finalized a pact to double its demand of Pfizer-BioNTech doses to 600 million.
Let us take a glance at their stock performances of Pfizer and BioNTech:
BioNTech SE (BNTX:US or NASDAQ: BNTX)
Current Stock Price: US$ 105.27
Units of the German drug maker have swelled as much as 165 per cent in one year. Its current market cap is approximately US$ 25.3 billion. However, the stock has plunged nearly 15 per cent in the last one month due to the new COVID-19 strain.
The stock has a 10-day average trading volume of 3.2 million and a price-to-book ratio of 22.162. The vaccine producer has almost 241 listed shares outstanding, as per TMX data.
@Kalkine Image 2021
Pfizer Inc. (PFE:US or NYSE: PFE)
Current Stock Price: US$ 37.42
The stock has added over 4 per cent growth in one year. The stock of US-based drug manufacturer has declined by 11 per cent in the last one month, driven by the new SARS-CoV-2 mutation outbreak.
Pfizer’s present market value stands at around US$ 208 billion. Its 10-day average volume is 30 million units. It has a total of 5.56 billion listed shares outstanding. The Covid-19 vaccine stock is offering a double-digit return on equity of 12.84 per cent, as per data on the TMX website.
